Goldman Sachs Group Inc. Has $4.66 Million Position in U.S. Physical Therapy, Inc. $USPH

Key Points

• Goldman Sachs Group Inc. reduced its stake in U.S. Physical Therapy by 21.9% during the 1st quarter, owning 64,411 shares worth approximately $4.66 million after selling 18,112 shares.
• Other hedge funds, includingMitsubishi UFJ Asset Management and Fifth Third Bancorp, significantly increased their positions in U.S. Physical Therapy during the same period.
• U.S. Physical Therapy declared a quarterly dividend of $0.45, resulting in a 2.3% dividend yield and an annualized payout of $1.80, with a payout ratio of 78.6%.

Goldman Sachs Group Inc. cut its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 21.9% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 64,411 shares of the company's stock after selling 18,112 shares during the quarter. Goldman Sachs Group Inc. owned approximately 0.42% of U.S. Physical Therapy worth $4,661,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of USPH. Cetera Investment Advisers grew its holdings in shares of U.S. Physical Therapy by 31.0% during the fourth quarter. Cetera Investment Advisers now owns 7,458 shares of the company's stock worth $662,000 after buying an additional 1,763 shares in the last quarter. Deutsche Bank AG grew its holdings in shares of U.S. Physical Therapy by 49.3% during the fourth quarter. Deutsche Bank AG now owns 13,176 shares of the company's stock worth $1,169,000 after buying an additional 4,350 shares in the last quarter. Lazard Asset Management LLC purchased a new stake in shares of U.S. Physical Therapy during the fourth quarter worth about $84,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of U.S. Physical Therapy by 3.4% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 8,506 shares of the company's stock worth $755,000 after buying an additional 282 shares in the last quarter. Finally, Nuveen Asset Management LLC grew its holdings in shares of U.S. Physical Therapy by 95.9% during the fourth quarter. Nuveen Asset Management LLC now owns 120,893 shares of the company's stock worth $10,724,000 after buying an additional 59,190 shares in the last quarter.

Insider Buying and Selling

In other U.S. Physical Therapy news, Director Nancy Ham sold 600 shares of the company's stock in a transaction dated Thursday, September 11th. The shares were sold at an average price of $81.71, for a total value of $49,026.00. Following the completion of the sale, the director directly owned 1,994 shares of the company's stock, valued at approximately $162,929.74. This represents a 23.13% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Eric Joseph Williams sold 1,000 shares of the company's stock in a transaction dated Friday, September 5th. The shares were sold at an average price of $85.25, for a total transaction of $85,250.00. Following the completion of the sale, the chief operating officer directly owned 25,331 shares of the company's stock, valued at $2,159,467.75. The trade was a 3.80% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 6,853 shares of company stock worth $581,406 in the last ninety days. Insiders own 2.00% of the company's stock.

U.S. Physical Therapy Stock Performance

Shares of USPH traded down $1.71 during midday trading on Friday, hitting $78.44. 246,355 shares of the stock traded hands, compared to its average volume of 113,523. U.S. Physical Therapy, Inc. has a 1-year low of $62.77 and a 1-year high of $101.19. The firm has a market capitalization of $1.19 billion, a PE ratio of 34.25, a price-to-earnings-growth ratio of 4.02 and a beta of 1.47. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.18 and a current ratio of 1.18. The business's 50 day moving average price is $80.21 and its two-hundred day moving average price is $76.48.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its quarterly earnings results on Wednesday, August 6th. The company reported $0.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.71 by $0.10. The company had revenue of $197.34 million during the quarter, compared to the consensus estimate of $190.24 million. U.S. Physical Therapy had a net margin of 5.05% and a return on equity of 8.78%. The company's revenue for the quarter was up 18.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.73 earnings per share. Equities research analysts predict that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 12th. Investors of record on Friday, August 22nd were issued a $0.45 dividend. The ex-dividend date of this dividend was Friday, August 22nd. This represents a $1.80 annualized dividend and a yield of 2.3%. U.S. Physical Therapy's dividend payout ratio is presently 78.60%.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the stock. JPMorgan Chase & Co. assumed coverage on shares of U.S. Physical Therapy in a research report on Thursday. They issued an "overweight" rating and a $110.00 target price on the stock. Barrington Research raised their target price on shares of U.S. Physical Therapy from $98.00 to $103.00 and gave the stock an "outperform" rating in a research report on Friday, August 8th. Wall Street Zen raised shares of U.S. Physical Therapy from a "hold" rating to a "buy" rating in a research report on Saturday, September 13th. Finally, Zacks Research raised shares of U.S. Physical Therapy to a "hold" rating in a research report on Friday, August 8th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $110.25.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.